ArticleScientific reports2025
Dermoscopically informed deep learning model for classification of actinic keratosis and cutaneous squamous cell carcinoma.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Artificial Intelligence in Inherited Epidermolysis Bullosa: Current Evidence, Challenges, and Future Directions.Diagnostics (Basel, Switzerland) · 2026Review
- Precision Diagnosis in Cutaneous Head and Neck Squamous Cell Carcinoma.Biomedicines · 2026Review
- Morphology-guided attention networks for explainable skin cancer detection under clinical uncertainty.Frontiers in oncology · 2026Article
- SCC-Net: A lightweight attention-enhanced deep learning model for automated squamous cell carcinoma detection.Digital healthArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate differentiation between actinic keratosis (AK) and cutaneous squamous cell carcinoma (cSCC) is crucial for effective treatment planning. While histopathology remains the gold standard, routine biopsy is often impractical for several reasons and dermoscopic evaluation is limited by overlapping features that lead to diagnostic uncertainty, even among experienced dermatologists. Artificial intelligence (AI), particularly convolutional neural networks (CNNs), has emerged as a powerful tool for automating image-based diagnosis in dermatology, achieving promising results in lesion classification. However, most of the existing models rely solely on raw images, overlooking the dermoscopic features that guide clinical reasoning. We developed a CNN-based model designed to classify AK versus cSCC in situ using dermoscopic images, integrating a dual-branch architecture that combines an EfficientNetB0 backbone for RGB inputs with a lightweight convolutional branch for two additional channels generated through targeted preprocessing to enhance vascular and keratinization patterns. Our dataset comprised 2,000 images, expanded through geometric and deep learning-based augmentation, exposing the model to nearly 200,000 training instances across epochs. Using repeated hold-out validation across 10 iterations, our best-performing model achieved an accuracy of 98.61%, sensitivity of 98.33%, specificity of 98.90%, precision of 98.90%, F1‑score of 98.61% and loss of 0.3120. These results surpass previously reported models for this task, demonstrating that incorporating clinically informed preprocessing significantly improves CNN performance. This approach represents a step toward clinically aligned AI systems capable of supporting dermatologists in differentiating between AK and cSCC with greater confidence and precision.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.